JuSun
Medical gadget maker NovoCure (NASDAQ:NVCR) added ~12%, marking its highest intraday achieve since November, after the corporate confirmed its participation on the J.P. Morgan Healthcare Convention subsequent month.
The developer of most cancers therapy, Tumor Treating Fields (TTFieds), is ready to fulfill traders and different capital market individuals on the occasion on Jan. 9 to Jan. 10.
The corporate has misplaced ~78% in worth this 12 months, pushed by a pointy selloff in August following a Part 3 setback for TTFieds, which it develops with Chinese language biotech Zai Lab Restricted (ZLAB).
The J.P. Morgan convention, a marquee occasion within the annual healthcare calendar, is scheduled to happen from Jan. 8 to Jan. 11 in San Francisco, California.
Root, Switzerland-based NVCR’s government chairman, William Doyle, will communicate on behalf of the corporate on Jan. 10 on the occasion. Its CFO, Ashley Cordova, will be part of him in one-on-one conferences with traders all through the convention.